Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GPCR |
---|---|---|
09:32 ET | 16085 | 41.51 |
09:34 ET | 17404 | 42.03 |
09:36 ET | 100 | 42.03 |
09:38 ET | 1195 | 42.379 |
09:39 ET | 1984 | 42.455 |
09:41 ET | 2150 | 42.49 |
09:43 ET | 779 | 42.4 |
09:45 ET | 1400 | 42.205 |
09:48 ET | 100 | 42.205 |
09:50 ET | 1950 | 42.16 |
09:52 ET | 1311 | 42.115 |
09:54 ET | 6915 | 42.1 |
09:56 ET | 300 | 42.01 |
09:57 ET | 1900 | 42.08 |
09:59 ET | 976 | 42.08 |
10:01 ET | 1400 | 42.02 |
10:03 ET | 13670 | 42.18 |
10:06 ET | 13700 | 42.475 |
10:08 ET | 8800 | 42.59 |
10:10 ET | 1434 | 42.7014 |
10:12 ET | 1170 | 42.78 |
10:14 ET | 988 | 42.79 |
10:15 ET | 350 | 42.85 |
10:17 ET | 1195 | 42.84 |
10:19 ET | 2735 | 43.115 |
10:21 ET | 3739 | 43.37 |
10:24 ET | 3100 | 43.06 |
10:26 ET | 800 | 43.1299 |
10:28 ET | 1850 | 43 |
10:30 ET | 625 | 43.165 |
10:32 ET | 801 | 43.35 |
10:33 ET | 3300 | 43.51 |
10:35 ET | 2721 | 43.88 |
10:37 ET | 1756 | 43.7133 |
10:39 ET | 850 | 43.51 |
10:42 ET | 1800 | 43.25 |
10:44 ET | 1382 | 43.34 |
10:46 ET | 300 | 43.335 |
10:48 ET | 538 | 43.335 |
10:50 ET | 2218 | 43.48 |
10:51 ET | 3582 | 43.47 |
10:53 ET | 1550 | 43.49 |
10:55 ET | 1332 | 43.44 |
10:57 ET | 4685 | 43.44 |
11:00 ET | 1983 | 43.45 |
11:02 ET | 1321 | 43.45 |
11:04 ET | 1000 | 43.42 |
11:06 ET | 550 | 43.46 |
11:08 ET | 1700 | 43.36 |
11:09 ET | 32753 | 43.15 |
11:13 ET | 500 | 43.235 |
11:15 ET | 402 | 43.315 |
11:18 ET | 2125 | 43.415 |
11:20 ET | 6150 | 43.3 |
11:22 ET | 200 | 43.3 |
11:26 ET | 3380 | 43.01 |
11:27 ET | 150 | 43.1303 |
11:29 ET | 800 | 43.17 |
11:31 ET | 700 | 43.175 |
11:33 ET | 100 | 43.175 |
11:36 ET | 2400 | 43.35 |
11:38 ET | 100 | 43.385 |
11:40 ET | 1550 | 43.49 |
11:42 ET | 200 | 43.555 |
11:44 ET | 700 | 43.65 |
11:45 ET | 11719 | 43.58 |
11:47 ET | 8362 | 43.42 |
11:49 ET | 3241 | 43.65 |
11:51 ET | 469 | 43.622 |
11:54 ET | 650 | 43.681041 |
11:56 ET | 550 | 43.84 |
11:58 ET | 7315 | 43.995 |
12:00 ET | 1300 | 44.11 |
12:02 ET | 353 | 44.2 |
12:03 ET | 4522 | 44.3 |
12:05 ET | 4578 | 43.955 |
12:07 ET | 22110 | 43.97 |
12:09 ET | 1900 | 43.74 |
12:12 ET | 8705 | 43.77 |
12:14 ET | 3400 | 43.85 |
12:18 ET | 200 | 43.91 |
12:20 ET | 500 | 43.825 |
12:21 ET | 2004 | 43.595 |
12:23 ET | 7895 | 43.58 |
12:25 ET | 300 | 43.75 |
12:27 ET | 370 | 43.745 |
12:30 ET | 100 | 43.755 |
12:32 ET | 200 | 43.775 |
12:34 ET | 200 | 43.75 |
12:36 ET | 1000 | 43.67 |
12:39 ET | 1100 | 43.445 |
12:41 ET | 641 | 43.4 |
12:43 ET | 300 | 43.41 |
12:45 ET | 2000 | 43.37 |
12:48 ET | 10132 | 43.4391 |
12:50 ET | 200 | 43.42 |
12:52 ET | 2988 | 43.31 |
12:54 ET | 100 | 43.3 |
12:56 ET | 200 | 43.32 |
12:57 ET | 100 | 43.365 |
12:59 ET | 1475 | 43.305 |
01:01 ET | 1350 | 43.08 |
01:03 ET | 150 | 43.3 |
01:06 ET | 200 | 43.19 |
01:08 ET | 2792 | 43.105 |
01:10 ET | 300 | 43.2044 |
01:12 ET | 2200 | 43.15 |
01:14 ET | 1600 | 43.005 |
01:17 ET | 100 | 43.04 |
01:19 ET | 500 | 43.105 |
01:21 ET | 300 | 43.105 |
01:24 ET | 700 | 43.115 |
01:26 ET | 400 | 43.115 |
01:28 ET | 500 | 43.115 |
01:30 ET | 800 | 43.16 |
01:33 ET | 300 | 43.135 |
01:35 ET | 2169 | 43 |
01:37 ET | 550 | 43.015 |
01:39 ET | 3077 | 43.02 |
01:42 ET | 7666 | 43.04 |
01:46 ET | 1752 | 43 |
01:48 ET | 3217 | 43.05 |
01:50 ET | 600 | 43.02 |
01:51 ET | 1000 | 43.035 |
01:53 ET | 1272 | 43.24 |
01:55 ET | 673 | 43.3175 |
01:57 ET | 958 | 43.2485 |
02:00 ET | 581 | 43.3 |
02:02 ET | 800 | 43.33 |
02:04 ET | 1074 | 43.48 |
02:06 ET | 1564 | 43.42 |
02:08 ET | 1945 | 43.11 |
02:11 ET | 200 | 43.2 |
02:13 ET | 500 | 43.2325 |
02:15 ET | 931 | 43.2785 |
02:18 ET | 1200 | 43.32 |
02:20 ET | 1251 | 43.315 |
02:22 ET | 950 | 43.41 |
02:24 ET | 872 | 43.4 |
02:26 ET | 1107 | 43.43 |
02:27 ET | 999 | 43.43 |
02:29 ET | 800 | 43.41 |
02:31 ET | 1400 | 43.335 |
02:33 ET | 1292 | 43.34 |
02:36 ET | 1699 | 43.42 |
02:38 ET | 1700 | 43.36 |
02:40 ET | 950 | 43.4 |
02:42 ET | 2650 | 43.385 |
02:44 ET | 18713 | 43.3 |
02:45 ET | 400 | 43.36 |
02:47 ET | 300 | 43.36 |
02:49 ET | 400 | 43.3987 |
02:51 ET | 100 | 43.27 |
02:54 ET | 600 | 43.37 |
02:58 ET | 100 | 43.335 |
03:00 ET | 2400 | 43.21 |
03:02 ET | 2164 | 43.42 |
03:03 ET | 400 | 43.42 |
03:05 ET | 2100 | 43.47 |
03:07 ET | 4320 | 43.515 |
03:09 ET | 1700 | 43.8075 |
03:12 ET | 506 | 43.86 |
03:14 ET | 1014 | 43.86 |
03:16 ET | 438 | 43.85 |
03:18 ET | 1877 | 43.75 |
03:20 ET | 200 | 43.75 |
03:21 ET | 1799 | 43.75 |
03:23 ET | 1556 | 43.82 |
03:25 ET | 1900 | 43.79 |
03:27 ET | 3015 | 43.77 |
03:30 ET | 600 | 43.795 |
03:32 ET | 839 | 43.725 |
03:34 ET | 7379 | 43.5975 |
03:36 ET | 400 | 43.62 |
03:38 ET | 3387 | 43.7 |
03:39 ET | 100 | 43.7 |
03:41 ET | 2523 | 43.57 |
03:43 ET | 1180 | 43.55 |
03:45 ET | 1251 | 43.56 |
03:48 ET | 1145 | 43.555 |
03:50 ET | 1510 | 43.575 |
03:52 ET | 2653 | 43.43 |
03:54 ET | 2407 | 43.62 |
03:56 ET | 3385 | 43.64 |
03:57 ET | 11547 | 43.58 |
03:59 ET | 41283 | 43.49 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Structure Therapeutics Inc | 2.4B | -19.4x | --- |
SpringWorks Therapeutics Inc | 2.4B | -7.4x | --- |
Verona Pharma PLC | 2.4B | -18.5x | --- |
CG Oncology Inc | 2.5B | -31.2x | --- |
Vera Therapeutics Inc | 2.3B | -19.0x | --- |
Immunitybio Inc | 2.5B | -3.8x | --- |
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.24 |
Book Value | $9.76 |
P/E Ratio | -19.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.